세계의 보톡스 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Botox is a purified form of botulinum toxin type A, a neurotoxin produced by the bacterium Clostridium botulinum. Botox works by blocking nerve signals to muscles, preventing them from contracting. This property makes it a versatile and widely recognized treatment in both medical and aesthetic fields.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types in the botox market are botulinum toxin type A and botulinum toxin type B. Botulinum toxin type A is used to block acetylcholine release for treating conditions such as chronic sialorrhea, muscle spasticity, and dystonia, in addition to its use in various cosmetic treatments. The applications include both therapeutic and aesthetic purposes, with end users ranging from hospitals and specialty clinics to dermatology clinics and other healthcare providers.

The botox market research report is one of a series of new reports from The Business Research Company that provides botox market statistics, including botox industry global market size, regional shares, competitors with a botox market share, detailed botox market segments, market trends, and opportunities, and any further data you may need to thrive in the botox industry. This botox market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The botox market size is expected to see rapid growth in the next few years. It will grow to $8,049.6 million in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to growing demand for aesthetic therapeutics, increasing demand for minimally invasive and non-invasive procedures, increasing demand for minimally invasive and non-invasive procedures, increasing demand for injectable aesthetic procedures, and increasing awareness and acceptance. Major trends in the forecast period include approval of large number of products, focusing on male aesthetics by offering tailored solutions, innovative product launches, collaboration between pharmaceutical companies for development, and advancements in botulinum toxin formulations.

The rising demand for cosmetic procedures is expected to significantly drive the growth of the botox market. Cosmetic procedures are primarily fueled by the growing desire for aesthetic enhancement, aided by advancements in minimally invasive techniques, increased influence from social media, and greater societal acceptance. The demand for cosmetic treatments is further supported by advancements in safer, minimally invasive technologies and rising disposable incomes. Social media's role in shaping appearance standards, alongside broader access to aesthetic treatments, is contributing to this trend. Botox plays a crucial role in these procedures by temporarily relaxing facial muscles to reduce the appearance of wrinkles, fine lines, and crow's feet, offering a smoother and more youthful appearance. According to the International Society of Aesthetic Plastic Surgery (ISAPS), 34.9 million aesthetic procedures were performed globally in 2023, a 3.4% increase from 2022. This growing demand for cosmetic procedures is fueling the botox market's expansion.

A key trend in the botox market is the development of innovations such as neurotoxin-based products, which are designed to target specific muscle groups, improve treatment precision, and expand the use of Botox in both aesthetic and therapeutic applications. Neurotoxins inhibit nerve function by blocking neurotransmitter release, making them effective in relaxing overactive muscles and reducing wrinkles. For example, in January 2023, Evolus, Inc. received regulatory approval for its neurotoxin product, Nuceiva (prabotulinumtoxinA), from the Australian Therapeutic Goods Administration (TGA). Nuceiva is aimed at temporarily improving the appearance of moderate to severe glabellar lines in adults. This product, derived from botulinum toxin type A, works by blocking acetylcholine release, which is responsible for muscle contraction.

In February 2022, Healis Therapeutics, a US-based biotechnology company, acquired an exclusive license for a botulinum toxin patent from AbbVie. The partnership focuses on developing a botulinum toxin candidate for treating major depressive disorder (MDD), showcasing Botox's growing therapeutic applications beyond cosmetic use.

Major players operating in the botox market are AbbVie, Ipsen, Evolus, Hugel, Galderma, Revance Therapeutics, Croma Pharma, and Merz Pharmaceuticals

North America was the largest region in the Botox market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in botox report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the botox market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botox market consists of sales of dysport, xeomin, and jeuveau. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botox Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botox market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botox ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The botox market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Botulinum Toxin Type A; Botulinum Toxin Type B
• 2) By Clinical Indication: Chronic Migraine; Cervical Dystonia; Blepharospasm; Overactive Bladder (OAB); Temporomandibular Joint (TMJ) Disorders
• 2) By Application: Therapeutics; Aesthetics
• 3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
• Companies Mentioned: AbbVie; Ipsen; Evolus; Hugel; Galderma; Revance Therapeutics; Croma Pharma; Merz Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Botox Market Characteristics

3. Botox Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Botox Market Trends And Strategies

5. Botox Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Botox Growth Analysis And Strategic Analysis Framework

• 6.1. Global Botox PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Botox Market Growth Rate Analysis
• 6.4. Global Botox Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Botox Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Botox Total Addressable Market (TAM)

7. Global Botox Market Pricing Analysis & Forecasts

8. Botox Market Segmentation

• 8.1. Global Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Botulinum Toxin Type A
• Botulinum Toxin Type B
• 8.2. Global Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Migraine
• Cervical Dystonia
• Blepharospasm
• Overactive Bladder (OAB)
• Temporomandibular Joint (TMJ) Disorders
• 8.3. Global Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Aesthetics
• 8.4. Global Botox Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Dermatology Clinics
• Other End Users

9. Global Botox Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Botox Market Regional And Country Analysis

• 10.1. Global Botox Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Botox Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Botox Market

• 11.1. Asia-Pacific Botox Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Botox Market

• 12.1. China Botox Market Overview
• 12.2. China Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Botox Market

• 13.1. India Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Botox Market

• 14.1. Japan Botox Market Overview
• 14.2. Japan Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Botox Market

• 15.1. Australia Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Botox Market

• 16.1. South Korea Botox Market Overview
• 16.2. South Korea Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Botox Market

• 17.1. Western Europe Botox Market Overview
• 17.2. Western Europe Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Botox Market

• 18.1. UK Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Botox Market

• 19.1. Germany Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Botox Market

• 20.1. France Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Botox Market

• 21.1. Eastern Europe Botox Market Overview
• 21.2. Eastern Europe Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Botox Market

• 22.1. North America Botox Market Overview
• 22.2. North America Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Botox Market

• 23.1. USA Botox Market Overview
• 23.2. USA Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Botox Market

• 24.1. Canada Botox Market Overview
• 24.2. Canada Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Botox Market

• 25.1. South America Botox Market Overview
• 25.2. South America Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Botox Market

• 26.1. Middle East Botox Market Overview
• 26.2. Middle East Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Botox Market

• 27.1. Africa Botox Market Overview
• 27.2. Africa Botox Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Botox Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Botox Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Botox Market Competitive Landscape And Company Profiles

• 28.1. Botox Market Competitive Landscape
• 28.2. Botox Market Company Profiles
  • 28.2.1. AbbVie Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Ipsen Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.3. Evolus Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.4. Hugel Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.5. Galderma Overview, Products and Services, Strategy and Financial Analysis

29. Global Botox Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Botox Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Botox Market

32. Recent Developments In The Botox Market

33. Botox Market High Potential Countries, Segments and Strategies

• 33.1 Botox Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Botox Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Botox Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer